The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Ashen and Blumenthal, N Engl J Med 353(12):1252-1260 September 22, 2005.

Correspondence
PreviousPrevious
Volume 354:417-419 January 26, 2006 Number 4
NextNext

Low HDL Cholesterol Levels

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Ashen, M. D.
-PubMed Citation
To the Editor: Ashen and Blumenthal (Sept. 22 issue)1 state that caution is recommended with the use of high-dose niacin in patients with diabetes, because niacin may increase glucose levels. However, the Arterial Disease Multiple Intervention Trial (ADMIT)2 showed that niacin can be used safely in patients with diabetes. Levels of glycosylated hemoglobin were unchanged from baseline in patients with diabetes who were assigned to receive niacin therapy. In fact, there were no differences in niacin discontinuation, niacin dosage, or hypoglycemic therapy in patients with diabetes who received niacin, as compared with baseline.

Previous reports of niacin-induced glucose intolerance are . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.